Efficacy, safety and prognostic factors analysis of first-line icotinib treatment in advanced non-small cell lung cancer patients with mutated EGFR
2018 ◽
Vol 7
(3)
◽
pp. 600-608
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 8
(2)
◽
pp. 185-191
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 7
(9)
◽
pp. 1361-1368
◽
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 15
(6)
◽
pp. 2465-2472
◽
Keyword(s):